| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $7.2B | $6.3B | $5.2B | $4.9B | $5.0B | $1.4B | $1.1B | — |
| Cost of Revenue | $3.0B | $2.6B | $2.2B | $2.1B | $2.1B | $1.7B | $1.5B | $1.4B |
| Gross Profit | $4.3B | $3.7B | $3.0B | $2.8B | $2.9B | $0.8B | $0.6B | $0.5B |
| R&D Expense | $1.1B | $1.0B | $0.9B | $0.8B | $0.8B | $0.7B | $0.6B | $0.6B |
| SG&A Expense | $1.3B | $1.1B | $0.8B | $0.8B | $0.7B | $0.6B | $0.5B | $0.5B |
| Operating Income | $1.9B | $1.6B | $1.1B | $1.0B | $1.2B | $1.1B | $0.9B | $0.8B |
| Net Income | $1.7B | $1.4B | $1.3B | $1.0B | $1.1B | $0.3B | $0.4B | $0.2B |
| EPS (Basic) | $8.65 | $7.35 | $6.74 | $5.06 | $5.63 | $1.73 | $1.90 | $1.01 |
| EPS (Diluted) | $8.59 | $7.30 | $6.71 | $5.04 | $5.61 | $1.73 | $1.89 | $1.00 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $11.0B | $9.6B | $8.6B | $7.7B | $7.9B | $7.0B | $6.2B | $5.4B |
| Current Assets | $6.2B | $5.3B | $4.5B | $4.0B | $4.3B | $3.7B | $3.1B | $2.7B |
| Cash & Equivalents | $2.3B | $2.1B | $1.7B | $1.3B | $1.5B | $1.5B | $1.0B | $1.2B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $1.7B | $1.5B | $1.3B | $1.2B | $1.4B | $1.2B | $1.0B | $0.9B |
| Stockholders' Equity | $9.0B | $7.8B | $7.0B | $6.2B | $6.1B | $5.5B | $4.8B | $4.2B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.6B | $1.4B | $1.4B | $0.8B | $1.0B | $1.1B | $0.7B | $0.9B |
| Investing Cash Flow | $-0.6B | $-0.4B | $-0.3B | $-0.1B | $-0.5B | $-0.3B | $-0.5B | $-0.3B |
| Capital Expenditures | $0.3B | $0.2B | $0.2B | $0.2B | $0.3B | $0.2B | $0.1B | $0.2B |
| Financing Cash Flow | $-0.8B | $-0.6B | $-0.6B | $-0.8B | $-0.5B | $-0.5B | $-0.4B | $-0.3B |